Books > Medicine > Clinical & internal medicine > Diseases & disorders > Oncology
|
Buy Now
EBNA1 and Epstein-Barr Virus Associated Tumours (Paperback, 2013 ed.)
Loot Price: R1,566
Discovery Miles 15 660
|
|
EBNA1 and Epstein-Barr Virus Associated Tumours (Paperback, 2013 ed.)
Series: SpringerBriefs in Cancer Research
Expected to ship within 10 - 15 working days
|
This SpringerBrief will a comprehensive account of the functions
and effects of the Epstein-Barr virus (EBV) EBNA1 protein that
relate to EBV-associated cancers and evidence for EBNA1
contributions to these cancers. EBNA1 was the first EBV protein
detected and the most critical for EBV latent infection. EBNA1
fulfills multiple functions at EBV genomes which have been
described in many (sometimes confusing) reports over the last 28
years. While these were initially thought to be the only roles of
EBNA1, many reports in recent years have shown that EBNA1 also
directly affects cellular processes in ways that would be expected
to contribute to oncogenesis. However, the degree to which EBNA1
promotes cell survival and oncogenesis in various types of human
tumours is not entirely clear and a matter of debate. This Brief
would offer a current synopsis of EBNA1 functions in EBV latency,
including functions in DNA replication, mitotic segregation and
transcription. Mechanisms of these EBNA1 functions will also be
discussed as well as implications for tumourigenesis. In addition,
the many cellular effects of EBNA1 will be reviewed, including how
EBNA1 manipulates specific cellular proteins and relationships to
EBV-associated lymphomas and carcinomas.
General
Is the information for this product incomplete, wrong or inappropriate?
Let us know about it.
Does this product have an incorrect or missing image?
Send us a new image.
Is this product missing categories?
Add more categories.
Review This Product
No reviews yet - be the first to create one!
|
|
Email address subscribed successfully.
A activation email has been sent to you.
Please click the link in that email to activate your subscription.